Plant Health Care (PHC ) has been awarded the London Stock Exchange's Green Economy Mark in recognition of its contribution to the global green economy.
Plant Healthcare has demonstrated more than 50% of revenues from environmentally sustainable products and services that contribute to the global green economy.
Plant Health Care stated it is committed to its Environmental, Sustainability Governance performance with its environmentally sustainable approach to protecting crops, promoting plant health and increasing yields while being readily compatible with mainstream agricultural practices.
The underlying methodology for the Green Economy Mark incorporates the “Green Revenues Data Model” has been developed and managed by FTSE Russell, the leading global index provider.
Chris Richards, CEO of Plant Health Care said, "I am delighted that Plant Health Care has been awarded the Green Economy Mark in recognition of our portfolio of environmentally friendly products. Our harpin-based products and PREtec technology are derived from natural proteins and represent a low impact approach to protecting crops and increasing yields while being compatible with mainstream agricultural practices.”
View from Vox
The award of the Green Economy Mark, whilst irrelevant in terms of future earnings, significantly improves the Company’s visibility to investors and other stakeholders interested in the global transition to a green and low carbon economy.
ESG investing is gaining rapid traction and the ability for PHC to champion its sustainable credentials will be key in attracting this sizeable investor group.
Reasons to PHC
London-listed Plant Health Care is a leading provider of proprietary agricultural biological products and technology solutions focused on improving crop performance.
Its commercial business is driven by sales of Harpin αß, a recombinant protein which acts as a powerful biostimulant, promoting the yield and quality of crops. PHC sells the proprietary soil treatment Myconate in selected countries and sells both Harpin αß and Myconate through specialist distributors globally. In Mexico, PHC distributes third-party biological products.
PHC utilises its PREtec platform to generate numerous products and it is focusing on three products targeting very large market opportunities with a value of more than $5bn.
The Group said these products are currently under evaluation with six potential commercial partners. Meanwhile, PHC also continues to evaluate further candidate products from its robust pipeline of development candidates for additional crops and indications.
In a trading update released in January 2021, the Group reported robust in-market sales growth of Harpin αβ with in-market sales in Brazilfor sugarcane coming in at three times those of 2019, while in-market sales to corn came in at 1.8 times higher than the prior year.
Meanwhile, the Group highlighted its progress in bringing the first products from the PREtec platform to market with planning for initial commercial launch in Brazil during the second half of 2021.